James R. Kasinger, General Counsel and Secretary of CRISPR Therapeutics AG ($CRSP), sold shares on the open market four times over the last year for a total of $462 thousand. His most recent sale occurred on March 11, 2026. These transactions rank 6,635th out of 11,678 insiders in our database, below the average sale amount of $8.6 million across 6.4 transactions per insider. Kasinger made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 3182 | $46.78 | 94,308.0000 | 95,985,312 | 3.26% | 0.00% |
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 6250 | $0.00 | 12,000.0000 | 95,985,312 | 34.25% | 0.01% |
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 95,985,312 | 9999.99% | 0.03% |
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Stock Option (Right to Buy) | 38499 | $0.00 | 38,499.0000 | 95,985,312 | 9999.99% | 0.04% |
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 6250 | $0.00 | 97,490.0000 | 95,985,312 | 6.85% | 0.01% |
| March 14, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 6875 | $0.00 | 20,625.0000 | 95,985,312 | 25.00% | 0.01% |
| March 14, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 6875 | $0.00 | 94,690.0000 | 95,985,312 | 7.83% | 0.01% |
| March 16, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 3450 | $48.26 | 91,240.0000 | 95,985,312 | 3.64% | 0.00% |
| March 10, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 5500 | $0.00 | 5,500.0000 | 95,985,312 | 50.00% | 0.01% |
| March 10, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 5500 | $0.00 | 90,615.0000 | 95,985,312 | 6.46% | 0.01% |
| March 11, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 2800 | $52.80 | 87,815.0000 | 95,985,312 | 3.09% | 0.00% |
| Feb. 18, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 3825 | $0.00 | 87,227.0000 | 95,985,312 | 4.59% | 0.00% |
| Feb. 19, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 2112 | $52.58 | 85,115.0000 | 95,985,312 | 2.42% | 0.00% |
| Feb. 18, 2026 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 3825 | $0.00 | 0.0000 | 95,985,312 | 100.00% | 0.00% |
| Oct. 13, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 2114 | $0.00 | 2,113.0000 | 85,774,474 | 50.01% | 0.00% |
| Oct. 13, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 2114 | $0.00 | 84,478.0000 | 85,774,474 | 2.57% | 0.00% |
| Oct. 14, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 1076 | $66.60 | 83,402.0000 | 85,774,474 | 1.27% | 0.00% |
| Oct. 3, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Stock Option (Right to Buy) | 16500 | $0.00 | 16,500.0000 | 85,774,474 | 9999.99% | 0.02% |
| March 20, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 6250 | $0.00 | 84,914.0000 | 85,774,474 | 7.95% | 0.01% |
| March 21, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 3185 | $41.23 | 81,729.0000 | 85,774,474 | 3.75% | 0.00% |
| March 20, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 6250 | $0.00 | 18,750.0000 | 85,774,474 | 25.00% | 0.01% |
| March 14, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Restricted Stock Units | 27500 | $0.00 | 27,500.0000 | 85,774,474 | 9999.99% | 0.03% |
| March 14, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Stock Option (Right to Buy) | 36666 | $0.00 | 36,666.0000 | 85,774,474 | 9999.99% | 0.04% |
| March 10, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 5500 | $0.00 | 11,000.0000 | 85,774,474 | 33.33% | 0.01% |
| March 11, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 2250 | $0.00 | 0.0000 | 85,774,474 | 100.00% | 0.00% |
| March 12, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 1116 | $43.32 | 78,664.0000 | 85,774,474 | 1.40% | 0.00% |
| March 11, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 2250 | $0.00 | 79,780.0000 | 85,774,474 | 2.90% | 0.00% |
| March 11, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 2850 | $42.42 | 77,530.0000 | 85,774,474 | 3.55% | 0.00% |
| March 10, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 5500 | $0.00 | 80,380.0000 | 85,774,474 | 7.35% | 0.01% |
| Feb. 19, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 1947 | $52.80 | 74,880.0000 | 85,774,474 | 2.53% | 0.00% |
| Feb. 18, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 3825 | $0.00 | 76,827.0000 | 85,774,474 | 5.24% | 0.00% |
| Feb. 16, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 20000 | $0.00 | 0.0000 | 85,774,474 | 100.00% | 0.02% |
| Feb. 18, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 3825 | $0.00 | 3,825.0000 | 85,774,474 | 50.00% | 0.00% |
| Feb. 18, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 9595 | $53.85 | 73,002.0000 | 85,774,474 | 11.62% | 0.01% |
| Feb. 16, 2025 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 20000 | $0.00 | 82,597.0000 | 85,774,474 | 31.95% | 0.02% |
| Oct. 16, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Stock Option (Right to Buy) | 18333 | $0.00 | 18,333.0000 | 0 | 9999.99% | 0.00% |
| Oct. 16, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Restricted Stock Units | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 13, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 2113 | $0.00 | 4,227.0000 | 0 | 33.33% | 0.00% |
| Oct. 13, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 2113 | $0.00 | 63,686.0000 | 0 | 3.43% | 0.00% |
| Oct. 14, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 1089 | $46.28 | 62,597.0000 | 0 | 1.71% | 0.00% |
| March 20, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Stock Option (Right to Buy) | 33333 | $0.00 | 33,333.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 1146 | $74.44 | 61,174.0000 | 0 | 1.84% | 0.00% |
| March 11, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 2250 | $0.00 | 2,250.0000 | 0 | 50.00% | 0.00% |
| March 10, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 5500 | $0.00 | 16,500.0000 | 0 | 25.00% | 0.00% |
| March 11, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 2801 | $78.26 | 60,070.0000 | 0 | 4.46% | 0.00% |
| March 10, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 5500 | $0.00 | 62,871.0000 | 0 | 9.59% | 0.00% |
| March 11, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 2250 | $0.00 | 62,320.0000 | 0 | 3.75% | 0.00% |
| Feb. 18, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 3825 | $0.00 | 7,650.0000 | 0 | 33.33% | 0.00% |
| Feb. 20, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | S | Common Shares | 1913 | $79.67 | 57,371.0000 | 0 | 3.23% | 0.00% |
| Feb. 18, 2024 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 3825 | $0.00 | 59,284.0000 | 0 | 6.90% | 0.00% |
| Oct. 13, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Stock Option (Right to Buy) | 16667 | $0.00 | 16,667.0000 | 0 | 9999.99% | 0.00% |
| Oct. 13, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Restricted Stock Units | 6340 | $0.00 | 6,340.0000 | 0 | 9999.99% | 0.00% |
| March 10, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Restricted Stock Units | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| March 11, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 2250 | $0.00 | 4,500.0000 | 0 | 33.33% | 0.00% |
| March 10, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 2833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 10, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| March 11, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 2250 | $0.00 | 55,866.0000 | 0 | 4.20% | 0.00% |
| March 13, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | F | Common Shares | 1283 | $43.22 | 53,616.0000 | 0 | 2.34% | 0.00% |
| March 10, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 2833 | $0.00 | 54,899.0000 | 0 | 5.44% | 0.00% |
| March 13, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | F | Common Shares | 1022 | $43.22 | 54,844.0000 | 0 | 1.83% | 0.00% |
| Feb. 18, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Restricted Stock Units | 3825 | $0.00 | 11,475.0000 | 0 | 25.00% | 0.00% |
| Feb. 21, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | F | Common Shares | 1950 | $48.26 | 52,066.0000 | 0 | 3.61% | 0.00% |
| Feb. 18, 2023 | CRISPR Therapeutics AG | $CRSP | KASINGER JAMES R. | General Counsel and Secretary | M | Common Shares | 3825 | $0.00 | 54,016.0000 | 0 | 7.62% | 0.00% |